WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Post-ICU Rehab Program Misses Mark for Improving Quality of Life

But the remote intervention showed signals of benefit over the longer term and in subgroups

Raccontata damedicalxpress.commedpagetoday.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo1 mesi fa

Post-ICU Rehab Program Misses Mark for Improving Quality of Life

But the remote intervention showed signals of benefit over the longer term and in subgroups

originale
medicalxpress.com1 mesi fa

Clinical trial of online rehabilitation at home offers hope of better recovery for intensive care survivors

A UK-wide trial, managed by Warwick Medical School, finds that online rehabilitation at home can meaningfully improve quality of life for some intensive care survivors. The iRehab Trial tested an online rehabilitation…

Leggi questa versione → originale

Timeline cronologica

  1. martedì 19 maggio 2026·medicalxpress.com

    Clinical trial of online rehabilitation at home offers hope of better recovery for intensive care survivors

    A UK-wide trial, managed by Warwick Medical School, finds that online rehabilitation at home can meaningfully improve quality of life for some intensive care survivors. The iRehab…

  2. mercoledì 20 maggio 2026·medpagetoday.com

    Post-ICU Rehab Program Misses Mark for Improving Quality of Life

    But the remote intervention showed signals of benefit over the longer term and in subgroups